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Simona M. Siboni, Marta Spreafico, Marzia Menegatti, Ida Martinelli
and Flora PeyvandiPlasminogen deficiency is a rare disease characterized by
ligneous conjunctivitis and infections. We observed a
3-year-old Italian boy presenting ligneous conjunctivitis and
low plasma levels of plasminogen. Twenty-three different
mutations on the PLG gene have been reported to date, but
mutation analysis had been troublesome for the presence
of highly homologous genes. The aim of the study was to
identify the underlying mutation avoiding coamplification of
unwanted genetic materials using a long polymerase chain
reaction strategy, instead of the previously reported
subcloning methods. By this simple strategy the complete
sequence analysis of PLG gene was performed, and a
previously reported missense homozygous mutation
(K19E) was identified. Blood Coagul Fibrinolysis 18:81–84
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Type I plasminogen deficiency is a rare condition that can
be associated with an uncommon and severe form of
ligneous conjunctivitis. This inherited disease mainly
affects children and is frequently associated with infec-
tions of the upper respiratory trait, otitis media and
vulvovaginitis, and it is characterized by conjunctival
wood-like consistency membranes due to fibrin depo-
sition. The severity of the disease is related to the degree
of plasminogen deficiency, which is caused by homozy-
gous or double heterozygous gene mutations transmitted
as an autosomal recessive trait [1]. The PLG gene, con-
sisting of 19 exons separated by 18 introns, spans about
52.5 kb on chromosome 6q26-27 [2]. The primary struc-
ture of PLG (791 amino acids) consists of a preactivation
peptide, five tandemly repeated ‘kringle’ domains and a
catalytic domain [2]. Plasminogen is activated by tissue
plasminogen activator or urokinase, resulting in the for-
mation of plasmin. Plasmin itself may cleave the carboxy-
terminal end of plasminogen or plasmin at Lys77–Lys78
residues, enhancing the affinity of the Lys-plasminogen
or plasmin for fibrin [3]. An extraordinary sequence
homology between PLG and apolipoprotein(a) (LPA)
genes was reported, suggesting the possibility of a com-
mon origin resulted from a gene duplication [4]. Further-
more, a 95% homology between the PLG gene sequence
and exons 1–5, 17, 18 and 19 of plasminogen-related
genes (PRGs genes) was reported [5]. Twenty-three
mutations on PLG gene have been previously described
[1,5–11], some of them reported in more than one patient
(A600T and K19E). In this report we describe themolecular characterization of a young patient affected
by plasminogen deficiency with ligneous conjunctivitis
and recurrent tracheo-bronchitis.
Materials and methods
Case report
A 3-year-old boy, the only child of healthy nonconsan-
guineous Italian parents, was referred to our centre for
plasminogen deficiency after two episodes of ligneous
conjunctivitis. His family history was negative. The
patient had suffered from recurrent tracheo-bronchitis
since the first year of life, with a frequency of four to six
episodes per year. His first ligneous conjunctivitis was
treated with aspecific eye-drop therapy, whereas the
second episode was treated with corticosteroid eye drops
and required surgical excision twice. Both episodes
involved the right eye. In September 2004, after the
diagnosis of plasminogen deficiency was completed,
he had a third episode of ligneous conjunctivitis in the
same eye. On this occasion the patient had early heparin
eye-drop treatment, and in approximately 1 week had
complete healing. Informed consent was obtained from
the patient’s family.
Plasminogen functional assay
A plasminogen functional activity in citrated plasma, after
activation with streptokinase and fibrinogen, was per-
formed using a chromogenic assay with p-nitroaniline as
the substrate. Plasminogen levels were revealed auto-
matically by the ACL system (Instrumentation Labora-
tory, Milan, Italy).orized reproduction of this article is prohibited.
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DNA extraction
Ten millilitres of peripheral blood were collected in
sodium citrate 0.105 mol/l from the patient and his
parents. Plasma and cells were separated after centrifu-
gation at 4000 g for 30 min. DNA was isolated from
blood cells according to the salting out method [12].
Amplification strategies
All coding regions and intron/exon boundaries of the PLG
gene were analysed by direct sequencing after polymer-
ase chain reaction (PCR) amplification, using sets of
intronic primers designed on the basis of previously
reported primer sequences [9]. Considering the extra-
ordinary sequence homology between PLG [National
Centre for Biotechnology Information (NCBI) accession
number NT_007422], LPA (NCBI accession number
NT_007422) and PRGs genes (NCBI accession number
NT_022184) [2,4], their sequences were aligned. This
allowed one to identify the most homologous regions and
to draw adequate sets of primers in order to avoid coam-
plification during the PCR. Specific sets of primers were
found to singly amplify all exons (see Table 1) except for
exons 1–5, 11, 12, 16 and 17. Exons 1–5 were therefore
amplified by a different strategy based on a long PCR,
using the forward primer of exon 1 and the reverse primer
of exon 5. The amplification was performed using theopyright © Lippincott Williams & Wilkins. Unautho
Table 1 Sequences of primers used to amplify and sequence each sin
Exon Sequences
1 50-ATTCAAGGTAATGTTTGAACC-30
50-AAATGAATTGCACATAAAGCC -30
2 50-AATGCCCGACTGTGTGTTCTTA-30
50-TTACAGATTCCTGCGTAGGTGCA-30
3 50-CTCTGGTCCCTCAAGATATTCA-30
50-ATAACACGATAGTGCCTTCCT-30
4 50-CTCAACGTGACTATGCTG-30
50-GAGGGACAACTTTACAGTAG-30
5 50-CTCCTTCTGCCTTGCTAATA-30
50-AGAGGTGAATACGTTACTC-30
6 50-CATCGGAATGAGAGGCAAGT-30
50-CAGCAAATGTCTGATAGAGC-30
7 50-AGCACACAGCAGGTGCTCAATG-30
50-GGCTGCACTCAGGCACTGACAC-30
8 50-CGCACCTGTAGTCTGAGCTACTCGG-30
50-CCAGAATACTTTATCCTGCGTTCC-30
9 50-CCGTAACGGTTGTTCTCAAAGCGTG-30
50-GCAGGCTTTCTGACCACAATAGC-30
10 50-TAATTCTCAGAGGCTACCGTACTGT-30
50-GGCTTGAAGCATGAAGCATGGC-30
11–12 50-TATTCTCCCACCTCTTGTGA-30
50-TCTGTAACACAGAACCAAT-30
13 50-GAAACACTCCTTTATGTCTTCTA-30
50-TGCTCAGAAGCCCTTTTCCTT-30
14 50-CTTGGAATTTGTCTCGAAT-30
50-GACAGTATAAATCGTTTCT-30
15 50-TTTCTGTACAATGGAGCAG-30
50-TATTTAAGACAAGACTTCA-30
16–17 50-ACCAATTTCATGGCACAGA-30
50-GTAGGTCAAAACCAATTCG-30
18 50-CTGGAATATCCTCCTGAAT-30
50-CAAGACTAACTTTGGTCTC-30
19 50-GCATCCCATAATAAAAGGC-30
50-TGCTAAATCCCTACCCACG-30
Amplicon sizes and annealing temperatures used during the polymerase chain reactioExpand Long Template PCR System (Roche, Penzberg,
Germany), according to the manufacturer’s instruction
with an annealing temperature of 528C. The obtained
fragment, 11 099 bp long, was resolved on 1.5% SeaKem
gel and then gel-extracted by the QIAquick Gel Extrac-
tion Kit (Qiagen, Hilden, Germany). Then 1ml of the
obtained solution was used as a template for further
nested PCRs using different sets of primers for each
exon (see Table 1). The fragments containing, respect-
ively, exons 11–12 and 16–17 were amplified using the
forward primer of exons 11 or 16 and the reverse primer of
exons 12 or 17 (Table 1) by two separate PCR amplifica-
tions. The obtained PCR fragments were sequenced
using both forward and reverse primers in order to analyse
the two comprised exons of each couple.
PCR and sequencing conditions
DNA samples were amplified by PCR in a final volume of
30ml with 0.33 mmol/l each primer, 0.2 mmol/l each
dNTP in 100 mmol/l Tris–HCl, pH 8.3, 500 mmol/l
KCl, 2 mmol/l MgCl2, 0.01 mg/l bovine serum albumin,
0.2 U AmpliTaq Gold polymerase (Applied Biosystems,
Foster City, California, USA), using a GeneAmp PCR
System 9700 thermal cycler (Applied Biosystems).
Amplification involved a denaturation cycle of 958C for
10 min and 35 amplification cycles followed by a finalrized reproduction of this article is prohibited.
gle exon of the PLG gene
Amplicon size (bp) Annealing temperature (8C)
304 52
354 66
334 58
244 52
327 52
307 51
304 63
438 63
350 64
341 63
963 54
285 58
232 60
183 47
2470 57
244 48
290 50
n are also shown.
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Table 2 Polymorphism genotypes in the proband and his parents
Polymorphism location Amino acid change Nucleotide change NCBI referencea
Genotype
Proband Mother Father
Intron F (14 bp upstream of exon 7) – T!G rs4252109 G/G T/G G/G
Exon 9 Gln342Gln A!G rs13231 G/G A/G G/G
Intron I (63 bp upstream of exon 10) – A!G rs4252117 G/G A/G G/G
Intron J (9 bp downstream of exon 10) – T!C rs4252120 C/C C/T C/C
Exon 11 Asp453Asn G!A rs4252125 A/A G/A A/A
Exon 19 Gly743Gly G! T rs11060 T/T G/T T/T
a Polymorphism registration number on the National Centre for Biotechnology Information (NCBI) single nucleotide polymorphisms database (http://www.ncbi.nlm.nih.
gov/).extension of 728C for 7 min. Each amplification cycle
involved a 30 s denaturation step at 958C, a 30 s or 2 min
annealing step, respectively, for a single exon or exons
11–12 and 16–17, at specific temperatures (Table 1), and
a 30 s elongation step at 728C.
Each PCR fragment was purified (QIAquick/PCR puri-
fication Kit; Qiagen) and subjected to direct sequencing
analysis in both the forward and reverse directions
using the Taq dye-deoxy terminator method and an
ABI PRISM 310 Genetic Analyser (Applied Biosystems).
All detected gene variations have been resequenced
and reconfirmed.
Results
Plasminogen functional assay
The assay performed on the affected patient showed a
plasminogen functional activity of 26.7% (normal
range, 72.9–126.9%). In his parents the plasminogen
values were slightly decreased (father, 63.9%; mother,
61.4%).
Molecular analysis
A previously reported missense homozygous A to G
substitution in exon 2, leading to the replacement of a
Lys by a Glu at codon 19 (K19E), was identified [1]. This
mutation is located in the proactivation peptide (NH2-
terminal acidic domain of plasminogen), 59 amino acids
upstream of the Lys77–Lys78 cleavage site. Both parents
were heterozygous for the same mutation. The gene
sequence analysis also revealed six additional polymorph-
isms located in exons 9, 11 and 19, and in introns F, I and
J, all previously reported (Table 2).
Discussion
The direct sequence analysis of fragments obtained by
PCR generally represents the fastest and simplest
strategy to search gene mutations. This strategy is more
complex in the case of the PLG gene because of the high
homology between PLG, LPA and PRGs genes. PLG and
PRGs share about 95% homology in the 50-untranslated
region and intron 5 region, whereas the LPA protease
domain and PLG protease domain sequences share 94%
homology [4]. These high homology percentages lead to
DNA fragment coamplification problems during PCR,opyright © Lippincott Williams & Wilkins. Unauthdue to the difficulty of drawing specific PLG gene sets of
primers. Previously, the amplification of PLG exons
followed by subcloning and sequencing of the M13 vector
was used to solve this problem [5,7]. Obviously, this
method leads to a certain result, but it is complex and
time consuming. In this study, the molecular analysis of
the PLG gene portion comprised of the 50-untranslated
region and intron E was carried out with a different
strategy based on the long PCR method in order to obtain
a fragment including exons 1–5. To remove any possible
trace of native DNA from the final solution, the product
of this reaction was gel extracted and then utilized as a
template to perform nested PCRs of each single exon.
For the amplification of exons 11, 12, 16 and 17, which
could also generate coamplification problems, the for-
ward primer of the upstream exons and the reverse primer
of the downstream exons of the couples composed of
exons 11–12 and 16–17 were used. The PCR products
were gel extracted and sequenced using both forward and
reverse primers for each fragment. These strategies led us
to identify finally a previously reported mutation, K19E
[1], and six polymorphisms (all registered in NCBI: http://
www.ncbi.nlm.nih.gov/) in a patient affected by plasmi-
nogen deficiency associated with ligneous conjunctivitis,
avoiding the coamplification of homologous plasminogen
sequences. In the proband, both the mutation and the six
polymorphisms were in a homozygous state. His non-
consanguineous parents were heterozygous for the K19E
mutation, while polymorphism analysis revealed a homo-
zygous pattern for the father and a heterozygous pattern
for the mother. We can thus conclude that in this family
the K19E mutation was associated with the same pattern
of the investigated polymorphisms.
In conclusion, the K19E mutation in the PLG gene is a
common genetic defect in individuals with hypoplasmi-
nogenaemia, including patients with ligneous conjuncti-
vitis, at least in Europe [1]. Surprisingly, this mutation
was also reported to be present in a Scottish healthy donor
population with a predicted homozygote prevalence of
0.4 in 1 000 000 in the Scottish general population [13].References
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